Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells
- PMID: 16437143
- DOI: 10.1038/sj.leu.2404114
Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
